Will it get a taste of CoVID-19 vaccine?

アップデート済
it was looking poised to reach 270-75 but got some pullbacks in past few weeks, it's looking strong technically and fundamentally (if it also gets some share in the development of vaccine) now though.
ノート
it has been trading in a consolidation phase, if it breaks 215 then 287 should be on the cards again.
Technical IndicatorspharmastocksTrend Analysis

他のメディア:

免責事項